文献速递瘢痕与激光

A型肉毒毒素与基质血管成分胶对兔耳增生性瘢痕治疗效果的比较研究

Comparison research on the therapeutic effects of botulinum toxin type A and stromal vascular fraction gel on hypertrophic scars in the rabbit ear model.
PubMed 文献 · Burns · 2023-09-17

该研究建立兔耳增生性瘢痕模型,分别单独或联合使用A型肉毒毒素(BTA)与基质血管成分胶(SVF-gel)治疗,于初始治疗后即刻、4周和8周进行曼彻斯特瘢痕量表(MSS)大体评估,并取组织行组织学和Western blot分析。结果显示所有治疗均通过抑制成纤维细胞活化、组织炎症及TGF-β1/Smad3通路不同程度减轻瘢痕增生,但含SVF-gel组在瘢痕外观和病理特征改善上不如单用BTA组,可能与M2型巨噬细胞(CD163+)滞留及TGF-β1表达部分维持有关。结论提示BTA抗瘢痕效果优于SVF-gel,两者联合无明显协同效应。

要点

  • BTA与SVF-gel单用或联用均可通过抑制成纤维细胞活化、炎症及TGF-β1/Smad3通路减轻兔耳瘢痕增生。
  • 含SVF-gel组瘢痕外观和病理特征改善不如单用BTA组,可能与M2型巨噬细胞滞留和TGF-β1表达部分维持有关。
  • 作者认为BTA抗瘢痕效果优于SVF-gel,两者联合未见明显协同效应。

核心结论

  • 作者认为BTA的抗瘢痕效果优于SVF-gel,且两者联合应用未见明显的协同效应。

研究设计与样本

  • 建立兔耳增生性瘢痕模型,分别以BTA、SVF-gel单用或联合治疗。
  • 于初始治疗后即刻、4周和8周采用曼彻斯特瘢痕量表(MSS)进行大体评估。
  • 取组织样本后进行组织学和Western blot分析。

主要发现

  • 所有治疗均通过抑制成纤维细胞活化(Ki-67、α-SMA)、组织炎症(CD45、IL-1β)及转化生长因子-β1(TGF-β1)/Smad3通路,不同程度减轻瘢痕增生。
  • 含SVF-gel组虽抗炎效果良好,但瘢痕外观和病理特征改善不如单用BTA组,可能与M2型巨噬细胞(CD163+)滞留及TGF-β1表达部分维持有关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Botulinum toxin type A (BTA) is often used for wrinkles and muscle convulsive diseases due to its blocking of the transmission of nerve impulses. Stromal vascular fraction gel (SVF-gel) prepared from adipose tissue has novel effects on skin depression and poor texture. Both BTA and SVF-gel are proved to possess anti-scar potential. This study aimed to assess and compare their therapeutic effects on hypertrophic scars. MATERIALS AND METHODS: The rabbit ear scar model was established and treated with BTA and SVF-gel, alone or in combination. Gross evaluation using Manchester Scar Scale (MSS) was conducted immediately, 4 and 8 weeks after initial treatment. After tissue sample harvest, histological and Western blot analyses were performed. RESULTS: All the treatments alleviated scar hyperplasia in different degrees by inhibiting fibroblast activation (Ki-67, α-SMA), tissue inflammation (CD45, IL-1β) and the transforming growth factor-β1 (TGF-β1)/Smad3 pathway. Despite an excellent anti-inflammatory effect, improvement of scar appearance and pathological characteristics in SVF-gel-contained groups was not as good as that in BTA-only group, which might be related to the retention of M2-type macrophages (CD163 +) and partial maintenance of TGF-β1 expression. CONCLUSION: Our data suggest that BTA has better anti-scar efficacy than SVF-gel, and the combination of these two treatments shows no obvious combinatorial effect.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Qian Y, Wei W, Pan T, et al. Comparison research on the therapeutic effects of botulinum toxin type A and stromal vascular fraction gel on hypertrophic scars in the rabbit ear model. Burns. 2023. PMID: 37783633. doi:10.1016/j.burns.2023.09.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。